England’s National Institute for Health and Care Excellence (NICE) has given a second thumbs down to a pair of Alzheimer’s ...

Myra Solano Garcia, who has Alzheimer's, says the drug Kisunla may be one reason she can still drive, cook, and sing.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The UK’s National Institute for Health and Care Excellence (NICE) has issued further draft guidance reaffirming its decision not to recommend the Alzheimer’s treatments Kisunla (donanemab ...

Heidi McWilliams, a 10-year Palm Beach resident, is chair of the organization's inaugural event at the Palm Beach County ...

Drugs can't stop Alzheimer's disease but sometimes, they can slow it down. This was one woman's experience taking the drug Kisunla.

Eli Lilly says a new starting dose regimen for its Alzheimer's disease therapy Kisunla reduces the risk of side effects that have stood in the way of approvals and reimbursement decisions for ...

The Food and Drug Administration approved the drug, now marketed as Kisunla, in July of 2024. It's one of two drugs approved since 2023 that can clear the brain of sticky amyloid plaques ...

HAMILTON: One reason may be the drug known generically as donanemab and marketed under the name Kisunla. It's one of two new drugs that can clear the brain of sticky amyloid plaques, one of the ...

Myra Solano Garcia, who has Alzheimer's, says the drug Kisunla may be one reason she can still drive, cook, and sing. Read part 1 of Jon's story. Drugs can't stop Alzheimer's disease yet.